Concepedia

Publication | Open Access

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders

DOIFull Paper Access

134

Citations

41

References

2021

Year

Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, Katinka Fischer, Anna Gahlen, Giovanni Novi, Helen Hayward-Könnecke, Sven Schippling, Paulus Rommer, Barbara Kornek,
Neurology Neuroimmunology & Neuroinflammation

Abstract

This study provides Class III evidence that long-term TCZ therapy is safe and reduces relapse probability in MOGAD and AQP4-IgG+ NMOSD.

References

YearCitations

Page 1